Bionano Genomics (BNGO) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 14, 2026, to be held virtually for stockholders of record as of March 19, 2026.

• Proxy materials, including the proxy statement and annual report, are available online, with options to request paper or email copies.

Voting matters and shareholder proposals

• Election of two Class II directors: Albert Luderer, Ph.D., and Kristiina Vuori, M.D., Ph.D.

• Advisory vote to approve compensation of named executive officers.

• Ratification of BDO USA, P.C. as independent registered public accounting firm for fiscal year ending December 31, 2026.

Board of directors and corporate governance

• Board recommends voting in favor of all three proposals presented at the annual meeting.